Lancet HIV, 8(2), e96-e105. ELSEVIER SCIENCE INC ATHENA observational cohort 2021, ' HCV micro-elimination in individuals with HIV in the Netherlands 4 years after universal access to direct-acting antivirals : a retrospective cohort study ', The Lancet HIV, vol. 8, no. 2, pp. e96-e105 . https://doi.org/10.1016/S2352-3018(20)30301-5 Lancet HIV, 8(2), e96-e105. Elsevier Limited The Lancet HIV, 8, 2, pp. e96-e105 The Lancet HIV, 8(2), e96-e105. Elsevier Limited The Lancet HIV, 8(2), e96-e105. Elsevier Ltd. The Lancet HIV, 8, e96-e105 The Lancet HIV, 8(2), E96-E105. ELSEVIER INC
International Journal of Dental Hygiene, 8(1), 63-67. Wiley Kranendonk, A A, van der Reijden, W A, van Winkelhoff, A J & van der Weijden, G A 2010, ' The bactericidal effect of a Genius Nd: YAG laser ', International Journal of Dental Hygiene, vol. 8, no. 1, pp. 63-67 . https://doi.org/10.1111/j.1601-5037.2009.00375.x International Journal of Dental Hygiene, 8(1), 63-67. Wiley-Blackwell
Journal of Clinical Periodontology, 28(11), 1004-1009. Wiley Reuland-Bosma, W, van der Reijden, W A & van Winkelhoff, A J 2001, ' Absence of a specific subgingival microflora in adults with Down's syndrome ', Journal of Clinical Periodontology, vol. 28, pp. 1004-1009 . https://doi.org/10.1034/j.1600-051X.2001.281103.x Journal of Clinical Periodontology, 28, 1004-1009. Blackwell Munksgaard
Journal of Controlled Release, 60, 49-56. Elsevier Ruissen, A L A, van der Reijden, W A, van 't Hof, W, Veerman, E C I & van Nieuw Amerongen, A 1999, ' Evaluation of the use of xanthan as vehicle for cationic anti-fungal peptides ', Journal of Controlled Release, vol. 60, pp. 49-56 . https://doi.org/10.1016/S0168-3659(99)00052-8
Annals of the Rheumatic Diseases, 58, 465-473. BMJ Publishing Group van der Reijden, W A, Vissink, A, Veerman, E C I & van Nieuw Amerongen, A 1999, ' Treatment of oral dryness related complaints (xerostomia) in Sjögren's syndrome ', Annals of the Rheumatic Diseases, vol. 58, pp. 465-473 . https://doi.org/10.1136/ard.58.8.465